Pozen secures second patent for its drug technology
Research Triangle Park, N.C. — Pozen (Nasdaq: POZN) hasn't gotten any pain relief from the FDA recently - but it has from the U.S. Patent and Trademark Office....
Please Log In to add a comment.
Latest for Insiders
- Google's 'reserve the date' notice could mean fiber for Triangle
- Just who is driving for Uber? And why? You might be surprised
- Cree's top exec gets a curve ball to end earnings call - Might he split the company?
- There's a RIoT going on in Durham - Internet of Things, that is - tonight
- As backlash against 'shared economy' grows, is this the next 'dot com' bomb?
- Governor's 'Innovation' plan shows potential for entire state, not just RTP
- Venture investor on NC deal flow: 'Great to be back in the top 10'
- Angel investor: VC stats 'moving in the right direction for us'
- Durham startup CEO on VC funding surge: 'I love it'
- Dow Jones: NC venture deals up in value but fall in raw numbers